T. Rowe Price Associates’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Sell |
24,263
-637
| -3% | -$866 | ﹤0.01% | 3033 |
|
|
2025
Q1 | $30K | Hold |
24,900
| – | – | ﹤0.01% | 2984 |
|
|
2024
Q4 | $41K | Hold |
24,900
| – | – | ﹤0.01% | 2951 |
|
|
2024
Q3 | $96K | Hold |
24,900
| – | – | ﹤0.01% | 2826 |
|
|
2024
Q2 | $73K | Buy |
24,900
+7,361
| +42% | +$21.6K | ﹤0.01% | 2796 |
|
|
2024
Q1 | $70K | Buy |
17,539
+1,786
| +11% | +$7.13K | ﹤0.01% | 2832 |
|
|
2023
Q4 | $79K | Buy |
15,753
+1,166
| +8% | +$5.85K | ﹤0.01% | 2741 |
|
|
2023
Q3 | $74K | Hold |
14,587
| – | – | ﹤0.01% | 2709 |
|
|
2023
Q2 | $74K | Buy |
+14,587
| New | +$74K | ﹤0.01% | 2744 |
|